Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2010-07-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1000475107PMID 20615947PMCID PMC2919921
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pillars Article: Regulation of Cutaneous Malignancy by γδ T Cells. Science. 2001. 294: 605-609.

  2018cited by this paper
• Epstein-Barr virus infection

  2012influential reference
• Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells

  2009cited by this paper
• IL-17 and Th17 Cells.

  2009cited by this paper
• Dengue Virus Infection and Virus-Specific HLA-A2 Restricted Immune Responses in Humanized NOD-scid IL2rγnull Mice

  2009cited by this paper
• Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

  2009cited by this paper
• Interleukin-17 and type 17 helper T cells.

  2009cited by this paper
• Antiretroviral Pre-exposure Prophylaxis Prevents Vaginal Transmission of HIV-1 in Humanized BLT Mice

  2008cited by this paper
• Humanized mice in translational biomedical research

  2007cited by this paper
• Human-hemato-lymphoid-system mice: opportunities and challenges.

  2007cited by this paper
• Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice

  2007cited by this paper
• Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

  2007cited by this paper
• Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region

  2007cited by this paper
• Thymic microenvironments for T cell differentiation and selection

  2006cited by this paper
• Three Memory Subsets of Human CD8+ T Cells Differently Expressing Three Cytolytic Effector Molecules1

  2006cited by this paper
• Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1

  2006cited by this paper
• HLA-A*0201-Restricted T Cells from Humanized NOD Mice Recognize Autoantigens of Potential Clinical Relevance to Type 1 Diabetes1

  2006cited by this paper
• Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

  2005cited by this paper
• Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice

  2005influential reference
• Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice

  2004cited by this paper
• Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12

  2004cited by this paper
• Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammacnull mice model.

  2003cited by this paper
• Complete reconstitution of human lymphocytes from cord blood CD34[+] cells using the NOD/SCID/γc null mice model

  2003cited by this paper
• Functional Human T Lymphocyte Development from Cord Blood CD34+ Cells in Nonobese Diabetic/Shi-scid, IL-2 Receptor γ Null Mice1

  2002cited by this paper
• NOD / SCID / cnull mouse : an excellent recipient mouse model for engraftment of human cells

  2002cited by this paper
• NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

  2002cited by this paper
• Regulation of Cutaneous Malignancy by γδ T Cells

  2001cited by this paper
• Regulation of cutaneous malignancy by gammadelta T cells.

  2001cited by this paper
• Epstein-Barr virus infection.

  2000cited by this paper
• HLA-A2.1–restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout Mice

  1997cited by this paper
• Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.

  1995cited by this paper
• Expression of perforin and membrane-bound lymphotoxin (tumor necrosis factor-beta) in virus-specific CD4+ human cytotoxic T-cell clones.

  1993cited by this paper
• Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody

  1988cited by this paper
• Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation.

  1988cited by this paper
• Epstein-Barr virus lymphoproliferation after bone marrow transplantation.

  1988cited by this paper
• Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro.

  1972cited by this paper

• Can Humanized Immune System Mouse and Rat Models Accelerate the Development of Cytomegalovirus-Based Vaccines Against Infectious Diseases and Cancers?

  2025cites this paper
• Humanized mouse models of KRAS-mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies

  2025cites this paper
• Engineering Mice to Study Human Immunity.

  2025cites this paper
• An HTLV-1-Infected Humanized Mouse Model Expressing HLA-A*02:01 Demonstrates Effective CTL-Mediated Suppression of HTLV-1

  2025cites this paper
• Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates

  2025cites this paper
• Humanized DRAGA mice are a valuable model to study novel immunotherapies for HIV-1

  2025cites this paper
• Clinical translation of TLR agonist-modified silicified cancer cell therapy supported by humanized mouse models

  2025cites this paper
• Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile

  2025cites this paper
• Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic

  2025cites this paper
• Human iPSC-derived nephron progenitor cells treat acute kidney injury and chronic kidney disease in mouse models.

  2025cites this paper
• EBV Infection and Its Immune Control in Humanized Mice.

  2025cites this paper
• Humanized Mouse Models of Epstein Barr Virus Infection

  2025cites this paper
• Filovirus Infection in Humanized Mouse Models.

  2025cites this paper
• Transcriptomic profiling reveals SARS-CoV-2-infected humanized MHC mice recapitulate human post vaccination immune responses

  2025cites this paper
• Delivery of CD47-SIRPα checkpoint blocker by BCMA-directed UCAR-T cells enhances antitumor efficacy in multiple myeloma.

  2024cites this paper
• Humanized Mouse Models of Bacterial Infections

  2024cites this paper
• Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model

  2024cites this paper
• T Cell Development and Responses in Human Immune System Mice.

  2024cites this paper
• Advancing Human Vaccine Development Using Humanized Mouse Models

  2024cites this paper
• MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers

  2024cites this paper
• HLA reduction of human T cells facilitates generation of immunologically multicompatible cellular products

  2024cites this paper
• Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia

  2023cites this paper
• Thymocyte Development of Humanized Mice Is Promoted by Interactions with Human-Derived Antigen Presenting Cells upon Immunization

  2023cites this paper
• Next-Generation Adjuvants: Applying Engineering Methods to Create and Evaluate Novel Immunological Responses

  2023cites this paper
• Production of Humanized Mice through Stem Cell Transfer

  2023cites this paper
• MHC class II‐deficient mice allow functional human CD4+ T‐cell development

  2023cites this paper
• Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies

  2023cites this paper
• A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains

  2023cites this paper
• Progress in building clinically relevant patient‐derived tumor xenograft models for cancer research

  2023cites this paper
• Recent Developments in NSG and NRG Humanized Mouse Models for Their Use in Viral and Immune Research

  2023cites this paper
• Patient-Derived-Xenografts in Mice: A Preclinical Platform for Cancer Research.

  2023cites this paper
• Humanized mouse models for immuno-oncology research

  2023cites this paper
• Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice

  2023cites this paper
• Toxicologic Neuropathology of Novel Biotherapeutics

  2023cites this paper
• Persistent hepatitis B virus and HIV coinfections in dually humanized mice engrafted with human liver and immune system

  2023cites this paper
• Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model.

  2023cites this paper
• Comparing Current and Next-Generation Humanized Mouse Models for Advancing HIV and HIV/Mtb Co-Infection Studies

  2022cites this paper
• EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer

  2022cites this paper
• Preclinical models for development of immune-oncology therapies.

  2022cites this paper
• Resolution of otitis media in a humanized mouse model

  2022cites this paper
• Can next-generation humanized mice that reconstituted with both functional human immune system and hepatocytes model the progression of viral hepatitis to hepatocarcinogenesis?

  2022influential citation
• A high-quality severe combined immunodeficiency (SCID) rat bioresource

  2022cites this paper
• Characterization and Function of Cryopreserved Bone Marrow from Deceased Organ Donors: A Potential Viable Alternative Graft Source

  2022cites this paper
• Critical evaluation of an autologous peripheral blood mononuclear cell-based humanized cancer model

  2022cites this paper
• Humanized mouse models for preclinical evaluation of HIV cure strategies.

  2022cites this paper
• Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies

  2022cites this paper
• Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor Mice

  2022cites this paper
• Patient-Derived Xenograft: A More Standard “Avatar” Model in Preclinical Studies of Gastric Cancer

  2022cites this paper
• Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation

  2022cites this paper
• HIV Latency in Myeloid Cells: Challenges for a Cure

  2022cites this paper
• PLK1‐dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV‐infected mice

  2021cites this paper
• Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse

  2021cites this paper
• Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy Development.

  2021cites this paper
• A novel clinically relevant graft‐versus‐leukemia model in humanized mice

  2021cites this paper
• Development of humanized mouse with patient‐derived xenografts for cancer immunotherapy studies: A comprehensive review

  2021cites this paper
• Inhibition of PLK1-dependent EBNA2 phosphorylation promotes lymphomagenesis in EBV-infected mice

  2021cites this paper
• Perspectives on Non-BLT Humanized Mouse Models for Studying HIV Pathogenesis and Therapy

  2021cites this paper
• Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity

  2021cites this paper
• Humanized Mice for the Evaluation of Novel HIV-1 Therapies

  2021cites this paper
• Animal Models of Hepatitis B Virus Infection–Success, Challenges, and Future Directions

  2021cites this paper
• Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation

  2021cites this paper
• Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models

  2021cites this paper
• In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling

  2021cites this paper
• Preclinical models and technologies to advance nanovaccine development.

  2021cites this paper
• Building the Next Generation of Humanized Hemato-Lymphoid System Mice

  2021cites this paper
• HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2 in Humanized Mice

  2021cites this paper
• Humanized NOD/SCID/IL2rγnull mice exhibit functionally augmented human regulatory T cells associated with enzymatic up‐regulation of H3K27me3 in comparison with humans

  2021cites this paper
• Establishment of Human Leukocyte Antigen-Mismatched Immune Responses after Transplantation of Human Liver Bud in Humanized Mouse Models

  2021cites this paper
• Establishment of Humanized Mice for the Study of HBV

  2021cites this paper
• Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice

  2021cites this paper
• Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies

  2021cites this paper
• Advances in Human Immune System Mouse Models for Studying Human Hematopoiesis and Cancer Immunotherapy

  2021influential citation
• Advances in Humanized Mouse Models to Improve Understanding of HIV-1 Pathogenesis and Immune Responses

  2021cites this paper
• Modeling human T1D-associated autoimmune processes

  2021cites this paper
• Understanding Normal and Malignant Human Hematopoiesis Using Next-Generation Humanized Mice.

  2020cites this paper
• Immune-mediated approaches against COVID-19

  2020cites this paper
• Leveraging Patient-Derived Models for Immunotherapy Research.

  2020cites this paper
• Animal Models Used in Hepatitis C Virus Research

  2020cites this paper
• Cryopreserved Human Oocytes and Cord Blood Cells Can Produce Somatic Cell Nuclear Transfer-Derived Pluripotent Stem Cells with a Homozygous HLA Type

  2020cites this paper
• Development and function of human dendritic cells in humanized mice models.

  2020cites this paper
• Improved human hematopoietic reconstitution in HepaRG co-transplanted humanized NSG mice

  2020cites this paper
• Autologously Humanized Mice for Immune‐Oncologic Studies

  2020cites this paper
• The Utility of Human Immune System Mice for High-Containment Viral Hemorrhagic Fever Research

  2020influential citation
• Modeling the Efficacy of Oncolytic Adenoviruses In Vitro and In Vivo: Current and Future Perspectives

  2020cites this paper
• Genetic Alterations and Checkpoint Expression: Mechanisms and Models for Drug Discovery.

  2020cites this paper
• Animal Models for Gammaherpesvirus Infections: Recent Development in the Analysis of Virus-Induced Pathogenesis

  2020cites this paper
• Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises

  2020cites this paper
• Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies

  2020cites this paper
• Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease, and Regenerative Medicine

  2020cites this paper
• Animal models for hepatitis B: does the supply meet the demand?

  2020cites this paper
• Kinomic profiling of tumour xenografts derived from patients with non-small cell lung cancer confirms their fidelity and reveals potentially actionable pathways.

  2020cites this paper
• Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy

  2020cites this paper
• Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies

  2020cites this paper
• Use of human splenocytes in an innovative humanised mouse model for prediction of immunotherapy‐induced cytokine release syndrome

  2020cites this paper
• Advances in Transgenic Mouse Models to Study Infections by Human Pathogenic Viruses

  2020cites this paper
• Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies

  2020cites this paper
• Current methods in translational cancer research

  2020cites this paper
• Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen

  2020cites this paper
• Humanized mouse model: a review on preclinical applications for cancer immunotherapy.

  2020cites this paper
• Cytotoxicity in Epstein Barr virus specific immune control.

  2020cites this paper